Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (10)
P 1 (3)

Trial Status

Completed12
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05058157Not ApplicableUnknownPrimary

Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae

NCT04276974Not ApplicableCompletedPrimary

Effects of an Organic Plant-rich Diet on Gut Microbiome and Vascular Function (ORGAMIC Pilot Study)

NCT03995602Not ApplicableCompletedPrimary

The Effects of Dragon Fruit Consumption on Vascular Function.

NCT04095949Not ApplicableCompletedPrimary

Absorption, Metabolism and Excretion of Artichoke Polyphenols in Healthy Individuals

NCT01706653Not ApplicableCompletedPrimary

The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health

NCT01836887Not ApplicableCompletedPrimary

The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health(2)

NCT03553225Not ApplicableCompletedPrimary

Randomized, Double-blind, Controlled Study to Evaluate the Effect of Concord Grape Extract on Vascular Function in Healthy Men and Women

NCT03202654Not ApplicableCompletedPrimary

Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation

NCT03485716Not ApplicableCompletedPrimary

Metabolic Dynamics During Physical Activity

NCT02799498Phase 1CompletedPrimary

Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection

NCT02588534Phase 1CompletedPrimary

Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects

NCT02179931Phase 1CompletedPrimary

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

NCT01643265Not ApplicableCompletedPrimary

Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids

Showing all 13 trials

Research Network

Activity Timeline